This Noom Med review covers the strongest compounded-medication program in our 2026 rankings — an 8.7/10, second only to Ro’s 8.8. One flat subscription bundles compounded semaglutide, clinician care, and the full psychology-based Noom coaching app, starting at $129 the first month.
The trade-offs are just as concrete. After month one, billing switches to quarterly lump sums — roughly $747 per 12 weeks on the semaglutide plan — compounded plans skip three states, and Noom’s own pages disagreed about their recurring prices when we checked in July 2026. Here is the full cost picture before you sign up.
What Is Noom Med?
Noom, Inc. is a New York digital health company founded in July 2008 by Saeju Jeong and Artem Petakov, best known for the psychology-based Noom weight loss app. Geoff Cook, former CEO of The Meet Group, took over as CEO in July 2023 — the same year Noom launched Noom Med, the telehealth arm that prescribes GLP-1 medication online.
Noom Med’s core products are subscription plans that bundle compounded semaglutide (GLP-1Rx) or compounded tirzepatide (GLP-1Rx Plus) with clinical care and Noom’s behavior-change curriculum. Around those sit a Microdose GLP-1Rx tier for low-dose therapy, a cheaper telehealth-only plan for brand-name drugs (Wegovy, Ozempic, Zepbound, Mounjaro) billed through insurance or cash pay, an oral metformin plan, and — since December 2025 — a Proactive Health program that pairs microdose GLP-1 with 17-marker at-home biomarker testing.
One thing needs stating plainly: compounded semaglutide and tirzepatide are not FDA-approved. Noom’s own disclaimer says the FDA has not reviewed them for safety, efficacy, or quality, and Noom discloses no affiliation with Novo Nordisk or Eli Lilly, the only makers of the approved versions. What sets Noom apart is the sourcing claim: per its September 2024 press release, its compounded medication is produced at an FDA-regulated 503B outsourcing facility using robotic sterile cGMP production — the stricter of the two compounding standards.
Noom Med Pricing in 2026
Every number below comes from Noom’s own pricing hub, verified in July 2026. All plans include the medication (except the brand-name plan), clinician care, and the full Noom app with 1:1 coaching.
| Plan | First Month | Ongoing Price |
|---|---|---|
| Microdose GLP-1Rx (low-dose compounded semaglutide) | $79 | $199/mo, billed quarterly |
| GLP-1Rx (compounded semaglutide) | $129 | $249/mo, billed quarterly |
| GLP-1Rx Plus (compounded tirzepatide) | $149 | $299/mo, billed quarterly |
| Brand-name plan (Wegovy, Ozempic, Zepbound, Mounjaro) | $39 | $99/mo, billed quarterly, plus medication cost |
| Metformin Weight Loss Pill plan | $69 | $99/mo, billed quarterly |
| Proactive Health GLP-1Rx (microdose + biomarker testing) | $149 per 4 weeks | $149 every 4 weeks (first term 15 weeks) |
Three billing rules matter before you commit. First, everything bills quarterly after month one. That advertised $249/month for compounded semaglutide arrives as one charge of roughly $747 per 12 weeks; the microdose plan’s product page spells out its cycle as $537 per 12 weeks. If a lump sum that size strains your budget, this is the wrong provider.
Second, promo prices jump sharply. The microdose tier goes from $79 the first month to $199/month — a jump of more than 150% — and semaglutide nearly doubles from $129 to $249. Treat the first-month number as a trial rate, not your bill.
Third, Noom’s own pages disagreed with each other when we checked. The pricing hub listed the microdose plan at $199/month and semaglutide at $249/month, while the individual product pages listed $179/month and $279/month the same week — the semaglutide product page bills $837 per 12-week cycle at that rate. These are likely promo or A/B-test variants, but it means you will not know your exact recurring charge until checkout.
A few more facts for the fine print: no insurance is required for compounded plans, subscriptions are FSA/HSA eligible, and Noom says you can cancel anytime — but we found no published refund policy. Noom also does not state whether the compounded price changes as your dose titrates; flat-price rivals usually advertise that promise explicitly, and Noom does not. And the $39-then-$99 brand-name plan does not include the drug — brand-name GLP-1s can run $1,000+/month without insurance coverage.
How Noom Med Works
Step 1: Health assessment. You complete an online questionnaire covering your goals and medical history. Eligibility depends on your BMI, medical history, and state of residence — and compounded plans are not offered in Alabama, Louisiana, or Mississippi.
Step 2: Clinician evaluation. A licensed clinician reviews your case via telehealth and prescribes only if it is clinically appropriate. A prescription is never guaranteed, which is how a legitimate provider should operate.
Step 3: Pharmacy and delivery. Compounded medication ships to your door — within 7 days, per Noom’s press release. Brand-name prescriptions are coordinated through a pharmacy using your insurance or cash pay.
Step 4: Ongoing care. Your subscription includes ongoing clinician access, prescription management, and refills where clinically appropriate — plus the Noom app curriculum, food logging, and 1:1 coaching that no other provider in our rankings bundles at this depth.
Noom Med Review: What Results Can You Expect?
Honest expectations start with the clinical trials — which tested the FDA-approved versions of these molecules, not Noom’s compounded copies. Weekly semaglutide 2.4 mg produced an average 14.9% body-weight loss over 68 weeks in the STEP 1 trial, and tirzepatide reached up to 20.9% over 72 weeks at the highest dose in SURMOUNT-1. Both trials paired medication with diet and exercise changes, and both ran well over a year — this is a slow build, not a sprint.
Noom’s marketing claims up to 33 pounds lost in 6 months on GLP-1Rx. Read the fine print: that number reflects the top 25th percentile of users, and Noom’s stated average is 25 pounds. The microdose tier claims up to 17 pounds in 60 days, with a stated average of 13 pounds. Averages, not promises — no provider can guarantee weight loss.
Customer feedback on the service is broadly positive but not spotless. Third-party roundups put Noom’s Trustpilot score at roughly 3.9–4.4 stars across 63,000+ reviews (we could not independently verify the figure). The BBB currently rates Noom A+ with accreditation since 2021, but the history matters: an older WebMD report cited 1,200+ BBB complaints and a past D rating, driven by billing and auto-renewal disputes, before the company cleaned up its record.
Noom Med vs Ro
Ro (8.8/10) edges out Noom Med by a tenth of a point in our rankings, but they win in opposite ways. Here is the head-to-head.
| Feature | Noom Med | Ro |
|---|---|---|
| Our score | 8.7/10 (Very Good) | 8.8/10 (Very Good) |
| Medication | Compounded semaglutide/tirzepatide (not FDA-approved), plus a brand-name pathway | FDA-approved brand-name only (Wegovy, Zepbound) |
| Starting price | $129 first month (semaglutide); $79 microdose | $199 first month for Wegovy pen, plus membership |
| Ongoing cost | $249/mo billed quarterly (~$747 per 12 weeks) | $149/mo membership + $199–$399/mo medication |
| Coaching | Full Noom app, curriculum, and 1:1 coaching included | Provider messaging, no behavior-change program |
| Insurance support | Brand plan uses your insurance for the drug; the program itself is not covered | Free coverage check + prior-authorization concierge |
| States served | Compounded plans exclude AL, LA, MS | All 50 states + D.C. |
| BBB record | A+, accredited since 2021 | B rating, 610 complaints |
Choose by supply chain and budget. Ro sells only FDA-approved medication through official Novo Nordisk and Eli Lilly channels and does real insurance legwork — but cash payers realistically face $350+ per month once the membership stacks on the medication, as our Ro review breaks down. Noom Med’s all-in compounded price undercuts that by $100+ per month and adds genuine coaching, at the cost of using medication the FDA has never reviewed.
If Noom’s compounded pricing is what draws you in, it is worth comparing the whole field first — our roundup of the best compounded semaglutide online puts Noom’s $249/month against rivals charging as little as $99.
Who Should Use Noom Med — and Who Shouldn’t
Use Noom Med if you want coaching built into the price. Every plan includes the full Noom curriculum, food logging, and 1:1 coaching alongside the medication. No other provider we rate above 8/10 bundles behavior change this deeply — and the Taper-Off Guarantee backs it up with a year of free Noom or medication discounts if you regain weight within 18 months of finishing the 12-month protocol.
Use Noom Med if you want to start low. The $79 first-month Microdose tier is a rare low-dose entry point, and the Proactive Health version adds 17-marker biomarker testing for $149 every 4 weeks. Compare the handful of GLP-1 microdosing providers before committing — this is still a young category.
Use Noom Med if 503B sourcing matters to you. If you are going to use compounded medication at all, Noom’s claim of an FDA-regulated 503B outsourcing facility with cGMP production is the stronger standard to look for.
Skip Noom Med if you live in Alabama, Louisiana, or Mississippi — the compounded plans are not available there. Skip it if quarterly lump sums are a problem: $747 every 12 weeks is a very different cash-flow commitment than $249 monthly. And skip it if you want only FDA-approved medication with a women-focused experience — our Hers review covers brand-name Wegovy pens from $199/month plus membership.
Standard qualification rules apply: telehealth providers generally require a BMI of 30+, or 27+ with a weight-related condition such as high blood pressure or type 2 diabetes. Expect disqualification for a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, or pregnancy. Noom’s Proactive Health microdose program is reportedly open at BMI 21+, per its December 2025 launch coverage.
Is Noom Med Legit? Our Verdict
Yes — Noom Med is legit, and at 8.7/10 (Very Good) it is the second-highest score on this site. This is an 18-year-old public-facing company, BBB A+ rated and accredited since 2021, with the best-documented compounding claim in the industry (a 503B facility with cGMP production, per Noom), a genuinely unique Taper-Off Guarantee, and the only serious coaching program bundled with GLP-1 medication anywhere in our rankings.
Legit does not mean flawless, and this Noom Med review would be useless if it soft-pedaled the problems. The core medication is compounded and not FDA-approved — Noom says so itself. Billing after month one arrives in quarterly lump sums of $537–$837 depending on plan and rate. Three states are excluded. Noom’s pricing hub and product pages showed conflicting recurring prices in the same week of July 2026, there is no published refund policy, and the company’s older BBB history of billing and auto-renewal complaints — since resolved — is worth remembering when you set a calendar reminder before each quarterly charge.
How This Noom Med Review Scored the Brand
Our score comes from the public 5-factor rubric on our How We Rank page: pricing transparency (30%), total cost (25%), safety and sourcing (20%), service flexibility (15%), and reputation (10%). Noom Med earns strong marks on total cost (no separate membership fee), safety disclosure (the 503B sourcing claim), flexibility (five distinct plan tiers), and reputation (BBB A+). It loses points on pricing transparency: the internal price inconsistencies, the sharp post-promo jumps, and its silence on whether cost changes with dose. These are editorial ratings built from documented research — provider pages, BBB records, press releases, and third-party review data verified in July 2026 — not first-hand drug testing, and not paid placement. If you want medication plus a real behavior-change program in one bill, Noom Med is the provider we would point you to first.